JCO Precision Oncology Conversations podcasts feature discussions with leading authors of JCO Precision Oncology articles, hosted by Dr. Abdul Rafeh Naqash. Join our experts in engaging conversations ...

Breakthrough research led by scientists in Manchester has identified a new drug combination that could improve outcomes for ...

New research from Dana-Farber Cancer Institute shows that a new class of drug results in cell death in cancers, such as small cell lung cancer, with a disabled quality control cell cycle checkpoint ...

The two main categories for lung cancer are small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Large cell lung cancer (LCLC) is a type of NSCLC. While the conditions share some ...

Ateganosine combined with Libtayo shows improved progression-free survival in advanced non-small cell lung cancer, suggesting potential long-term use. Spevatamig, a bispecific antibody, is being ...

World Lung Cancer Day has been observed every year on August 1 since 2012 to raise awareness about the risk of the disease.

Lung cancer is especially dangerous because its symptoms often do not appear until the harmful cells have already spread through the body. However, there are some early warning signs you might be able ...

It's natural to feel afraid after a lung cancer diagnosis. But there's also real reason for hope, as treatment for lung cancer has improved dramatically in the last decade. (DigitalVision/Getty Images ...